X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $20.49 | -1,100 | 209,178 | -1% | -$22,539 | ||||||
2024-10-15 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $21.03 | -2,011 | 210,278 | -1% | -$42,281 | ||||||
2024-09-19 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.04 | -24 | 212,289 | 0% | -$577 | ||||||
M | 2024-09-17 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.34 | -97 | 212,313 | 0% | -$2,361 | |||||
2024-09-10 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.25 | -1,811 | 212,410 | -1% | -$42,106 | ||||||
2024-07-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.74 | -1,820 | 209,171 | -1% | -$43,199 | ||||||
2024-06-21 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $20.24 | -27 | 210,991 | 0% | -$546 | ||||||
M | 2024-06-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $19.53 | -107 | 211,018 | 0% | -$2,089 | |||||
2024-04-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.85 | -269 | 211,125 | 0% | -$6,146 | ||||||
2024-04-15 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.86 | -2,212 | 211,394 | -1% | -$50,561 | ||||||
2024-04-08 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.62 | -4,161 | 213,606 | -2% | -$94,122 | ||||||
2024-03-20 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.66 | -30 | 211,154 | 0% | -$710 | ||||||
M | 2024-03-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.16 | -448 | 211,184 | 0% | -$10,378 | |||||
M | 2024-01-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.15 | -32,977 | 211,632 | -13% | -$796,441 | |||||
M | 2023-12-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.21 | -259 | 222,609 | 0% | -$6,011 | |||||
2023-10-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $16.61 | -2,078 | 222,868 | -1% | -$34,514 | ||||||
2023-09-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $19.67 | -130 | 224,946 | 0% | -$2,557 | ||||||
D | 2023-09-13 | PHR | Linetsky David | SVP, Life Sciences | S - Sale+OE | $20.34 | -2,178 | 225,076 | -1% | -$44,299 | |||||
2023-02-02 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $39.55 | -11,378 | 211,072 | -5% | -$449,989 | ||||||
2022-12-13 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $34.61 | -11,377 | 191,119 | -6% | -$393,755 | ||||||
2022-12-09 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $29.78 | -26,837 | 202,496 | -12% | -$799,072 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |